Inventor · disambiguated record
Weimin Zhu
Also filed as: ZHU WEIMIN
24 granted patents·12 pending applications·235 citations·filing 1996–2023
96Inventor score
Files withAPEXIGEN INC12EPITOMICS INC7ZHEJIANG NANOMAB TECH CENTER CO LTD5KE YAOHUANG2EPITOMICS INC C O ABCAM PLC1
Top patents by PatentIndex Score
36 records- 0198US9266956B2Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodiesAPEXIGEN INC·Filed 2015·Granted Feb 23, 2016·22 cites·28 claims
- 0297US7429487B2Fusion partner for production of monoclonal rabbit antibodiesEPITOMICS INC·Filed 2006·Granted Sep 30, 2008·62 cites·6 claims
- 0396US8957193B2Polynucleotides encoding anti-CD40 antibodiesAPEXIGEN INC·Filed 2014·Granted Feb 17, 2015·21 cites·10 claims
- 0495US9556278B2Anti-CD40 antibodiesAPEXIGEN INC·Filed 2016·Granted Jan 31, 2017·9 cites·10 claims
- 0595US8778345B2Anti-CD40 antibodiesZHANG YONGKE·Filed 2012·Granted Jul 15, 2014·40 cites·15 claims
- 0692US7732168B2Fusion partner for production of monoclonal rabbit antibodiesEPITOMICS INC·Filed 2008·Granted Jun 8, 2010·11 cites·12 claims
- 0791US8367408B2Fusion partner for production of monoclonal rabbit antibodiesEPITOMICS INC·Filed 2011·Granted Feb 5, 2013·7 cites·7 claims
- 0889US9994640B2Anti-CD40 antibodiesAPEXIGEN INC·Filed 2017·Granted Jun 12, 2018·6 cites·9 claims
- 0989US9676861B2Anti-CD40 antibodies and methods of useAPEXIGEN INC·Filed 2013·Granted Jun 13, 2017·9 cites·10 claims
- 1088US7803371B2Anti-VEGF antibodyEPITOMICS INC·Filed 2008·Granted Sep 28, 2010·10 cites·13 claims
- 1187US11001637B2Anti-CD40 antibodiesAPEXIGEN INC·Filed 2016·Granted May 11, 2021·2 cites·11 claims
- 1285US8062867B2Fusion partner for production of monoclonal rabbit antibodiesPYTELA ROBERT·Filed 2010·Granted Nov 22, 2011·6 cites·12 claims
- 1385US2024158523A1Anti-cd40 antibodies and methods of useAPEXIGEN INC·Filed 2023·Application pending·0 cites
- 1484US11712066B2Measurement circuit and measurement method for measuring and updating a voltage resolution of an electronic atomizer circuitWUXI CRYSTAL SOURCE MICRO ELECTRONICS CO LTD·Filed 2022·Granted Aug 1, 2023·1 cites·10 claims
- 1583US6891154B2Amino acid sequence pattern matchingSYN X PHARMA INC·Filed 2002·Granted May 10, 2005·13 cites·16 claims
- 1677US8088375B2Anti-VEGF antibodyKE YAOHUANG·Filed 2010·Granted Jan 3, 2012·3 cites·19 claims
- 1776US2022049005A1Anti-cd40 antibodies and methods of useAPEXIGEN INC·Filed 2021·Application pending·0 cites
- 1872US2022049006A1Anti-cd40 antibodies and methods of useAPEXIGEN INC·Filed 2021·Application pending·0 cites
- 1971US10259878B2Anti-RANKL antibodies and methods of useAPEXIGEN INC·Filed 2014·Granted Apr 16, 2019·1 cites·21 claims
- 2068US8986692B2Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibodyLi pierre·Filed 2010·Granted Mar 24, 2015·4 cites·13 claims
- 2167US9328333B2Fusion partner for production of monoclonal rabbit antibodiesEPITOMICS INC·Filed 2013·Granted May 3, 2016·0 cites·10 claims
- 2265US10377814B2Fusion partner for production of monoclonal rabbit antibodiesEPITOMICS INC·Filed 2016·Granted Aug 13, 2019·0 cites·20 claims
- 2363US2014349393A1Fusion Partner for Production of Monoclonal Rabbit AntibodiesEPITOMICS INC C O ABCAM PLC·Filed 2014·Application pending·0 cites
- 2460US2018273630A1Anti-cd40 antibodies and methods of useAPEXIGEN INC·Filed 2018·Application pending·0 cites
- 2553US5808026ASequence of AF1q cDNAHSC RES DEV LP·Filed 1996·Granted Sep 15, 1998·8 cites·5 claims
- 2653US2019309080A1Anti-rankl antibodies and methods of useAPEXIGEN INC·Filed 2019·Application pending·0 cites
- 2749US12442106B2Sequence-based high throughput method generating camelids antibodies to cover broad epitopes with high-resolutionZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2020·Granted Oct 14, 2025·0 cites·9 claims
- 2848US9441042B2Anti-KDR antibodies and methods of useKE YAOHUANG·Filed 2012·Granted Sep 13, 2016·0 cites·20 claims
- 2946US2024174760A1Nanobody targeting bcma and application thereofZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2022·Application pending·0 cites
- 3046US2025333508A1CTLA-4 Binding Molecule and Use ThereofZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2022·Application pending·0 cites
- 3145US2025215092A1Human Epidermal Growth Factor Receptor Binding Molecule and Use ThereofZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2022·Application pending·0 cites
- 3244US2024190986A1Mesothelin binding molecule and application thereofZHEJIANG NANOMAB TECH CENTER CO LTD·Filed 2021·Application pending·0 cites
- 3343US11007106B2Postoperative functional exerciser for frozen shoulderSHENZHEN SECOND PEOPLES HOSPITAL·Filed 2018·Granted May 18, 2021·0 cites·13 claims
- 3441US2004111757A1Multiplex system for production and screening of monoclonal antibodiesZHANG DONGXIAO·Filed 2002·Application pending·0 cites
- 3540US2004067496A1System for production and screening of monoclonal antibodiesFiled 2002·Application pending·0 cites
- 3638US10934524B2High throughput monoclonal antibody generation by B cell panning and proliferationEPITOMICS INC·Filed 2016·Granted Mar 2, 2021·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Weimin Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →